Artificial activation of bovine and equine oocytes with cycloheximide, roscovitine, strontium, or 6-dimethylaminopurine in low or high calcium concentrations


Autoria(s): Fernandes, Claudia Barbosa; Devito, Liani Gasparini; Martins, Lilian Rigatto; Pria Blanco, Ieda Dala; Lima Neto, Joao Ferreria de; Tsuribe, Patricia Myakawa; Pereria Goncalves, Camila Gabriela; Landim-Alvarenga, Fernanda da Cruz
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

03/12/2014

03/12/2014

01/08/2014

Resumo

Knowledge on parthenogenetic activation of oocytes is important to improve the efficiency of nuclear transfer (NT) and intracytoplasmic sperm injection (ICSI) because artificial activation of oocyte (AOA) is an essential step to achieve embryo production. Although different procedures for AOA have been established, the efficiency of in vitro production of embryos remains low, especially in equines and Bos taurus bovines. In an attempt to improve the techniques of NT and ICSI in bovine and equine species, we tested different combinations of drugs that had different mechanisms of action for the parthenogenetic activation of oocytes in these animals. The oocytes were collected, in vitro matured for 24 to 30 h and activated artificially, in the presence of low or high concentrations of calcium, with combinations of calcium ionophore (ionomycin) with cycloheximide, roscovitine, strontium, or 6-dimethylaminopurine (6-DMAP). For assessment of activation rates, oocytes were stained with Hoechst 33342 and observed under an inverted microscope. We showed that all combinations of drugs were equally efficient in activating bovine oocytes, with the best results obtained when high concentrations of calcium were adopted. For equine oocytes, high concentrations of calcium were not beneficial for the parthenogenetic activation and the combination of ionomycin with either 6-DMAP or roscovitine was effective in inducing artificial activation of oocytes. We believe that our preliminary findings provide some clues for the development of a better AOA protocol to be used with these species.

Formato

387-394

Identificador

http://dx.doi.org/10.1017/S0967199412000627

Zygote. New York: Cambridge Univ Press, v. 22, n. 3, p. 387-394, 2014.

0967-1994

http://hdl.handle.net/11449/112375

10.1017/S0967199412000627

WOS:000338197000012

Idioma(s)

eng

Publicador

Cambridge University Press

Relação

Zygote

Direitos

closedAccess

Palavras-Chave #Cloning #ICSI #Nuclear transfer #Parthenogenetic activation
Tipo

info:eu-repo/semantics/article